Albemarle Corp

Chart & Performance

D1W1MN

P/E

6.56

P/S

1.07

EPS

13.39

Div Yield, %

1.81%

Shrs. gr., 5y

1.47%

Rev. gr., 5y

23.30%

Revenues

9.62b

+31.38%

Net income

1.57b

-22.98%

CFO

1.33b

-30.53%

Dividend

Sep 13, 20240.405 USD/sh

Earnings

Feb 12, 2025

Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

URL

https://www.albemarle.com/

IPO date

Feb 22, 1994

Employees

7,400

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	9,617,203 31.38%	7,320,104 119.96%
Cost of revenue	8,517,019	4,317,498
Unusual Expense (Income)
NOPBT	1,100,184	3,002,606
NOPBT Margin	11.44%	41.02%
Operating Taxes	430,277	390,588
Tax Rate	39.11%	13.01%
NOPAT	669,907	2,612,018
Net income	1,573,476 -22.98%	2,042,856 1,551.83%
Dividends	(187,188)	(184,429)
Dividend yield	1.10%	0.72%
Proceeds from repurchase of equity	(27,468)	(10,555)
BB yield	0.16%	0.04%
Debt
Debt current	662,105	2,128
Long-term debt	3,872,848	3,314,241
Deferred revenue	78,027
Other long-term liabilities	753,951	828,918
Net debt	2,263,494	666,674
Cash flow
Cash from operating activities	1,325,321	1,907,849
CAPEX	(2,149,281)	(1,261,646)
Cash from investing activities	(2,781,160)	(1,422,649)
Cash from financing activities	623,911	611,887
FCF	(2,734,634)	694,043
Balance
Cash	889,900	1,499,142
Long term investments	1,381,559	1,150,553
Excess cash	1,790,599	2,283,690
Stockholders' equity	6,712,582	5,250,007
Invested Capital	13,023,266	9,818,299
ROIC	5.87%	29.42%
ROCE	7.16%	23.86%
EV
Common stock shares outstanding	117,766	117,793
Price	144.48 -33.38%	216.86 -7.23%
Market cap	17,014,832 -33.39%	25,544,590 -6.23%
EV	19,531,245	26,419,484
EBITDA	1,530,128	3,303,447
EV/EBITDA	12.76	8.00
Interest	116,072	122,973
Interest/NOPBT	10.55%	4.10%